Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
The process of introducing a new medication to the market, starting from initial development to the final launch, is both time-intensive and heavily regulated, often spanning over a decade or more. Achieving success in this endeavor hinges on the timely availability of precise analytical data, which is essential for making informed decisions during the early stages of development and reducing the likelihood of setbacks later on. Modern drug development primarily follows a systematic approach, with the crucial first step usually being the identification of a biological target to concentrate efforts on. This target identification demands a comprehensive understanding of the characteristics of the candidates, enabling swift and reliable identification of the most promising options. After establishing a biological target, the next significant hurdle is identifying the most advantageous lead molecules, which entails discovering potential drug candidates—these may include small organic compounds or biological constructs with therapeutic capabilities. Thus, the entire journey from concept to market is a complex interplay of scientific insight and strategic decision-making.
Description
alvaMolecule serves as a no-code cheminformatics platform designed to visualize, curate, and standardize molecular datasets in preparation for analysis. It accommodates popular molecular formats, including SMILES and SDF/MOL2, allowing users to navigate through collections in either grid or spreadsheet formats, with automatic import of relevant data. This tool ensures structure verification and standardization via pre-set standardizers and customizable SMIRKS rules, facilitates the identification and management of duplicates, and provides scaffold analysis for summarizing fundamental frameworks.
Additionally, it features integrated filters and charting options that allow sorting based on substructures, calculated molecular descriptors, and physicochemical properties. alvaMolecule is capable of calculating around 88 structural and physicochemical properties, which encompass drug-like and lead-like scores such as LogP, TPSA, and the Lipinski alert index, ultimately assisting users in generating high-quality datasets for QSAR/QSPR modeling, descriptor calculations, and virtual screening processes. Furthermore, its user-friendly interface ensures that researchers, regardless of their coding expertise, can easily navigate and utilize the tool to enhance their cheminformatics tasks effectively.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Bruker
Founded
1960
Country
United States
Website
www.bruker.com/en/applications/pharma/drug-discovery.html
Vendor Details
Company Name
Alvascience
Founded
2018
Country
Italy
Website
www.alvascience.com